Metabolic dysregulation in ALS is unraveled on a molecular level in vitro and in vivo (85). Lactate triggers neuroprotective signals in the brain (54). ALS-mutations impair the PGC-1α response in patient-derived iPS cells (70). Metabolic responses differ fundamentally in peripheral vs. central ALS-tissues (79).